Nephros (NEPH) Operating Expenses (2010 - 2026)

Nephros has reported Operating Expenses for 17 years, with the latest figure at $2.8 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 10.44% year-over-year to $2.8 million in Q2 2026; TTM through Jun 2026 was $11.1 million, a 19.67% increase from a year earlier, with the FY2025 full-year figure at $10.5 million, up 20.21% from the prior year.
• Operating Expenses was $2.8 million for Q2 2026 at Nephros, down from $2.9 million in the prior quarter.
• The five-year high for Operating Expenses was $2.9 million in Q1 2026, with the low at $1.9 million in Q3 2024.
• Average Operating Expenses over 5 years is $2.4 million, with a median of $2.5 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses fell 19.18% in 2024, then surged 33.87% in 2025.
• Over 5 years, Operating Expenses stood at $2.2 million in 2022, then rose by 21.25% to $2.7 million in 2023, then decreased by 19.18% to $2.2 million in 2024, then grew by 27.11% to $2.7 million in 2025, then gained by 2.55% to $2.8 million in 2026.
• The last three Operating Expenses figures came in at $2.8 million (Q2 2026), $2.9 million (Q1 2026), and $2.7 million (Q4 2025), per Business Quant data.